Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1452)
- Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. (2024/05/01) ♡
- Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. (2024/05/01) ♡
- Periportal macrophages protect against commensal-driven liver inflammation. (2024/05/01) ♡
- The potential of volatile organic compounds to diagnose primary sclerosing cholangitis. (2024/04/27) ♡
- Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease. (2024/04/04) ♡
- Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. (2024/04/03) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Primary sclerosing cholangitis with high immunoglobulin-G4. (2024/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP. (2024/04/01) ♡
- ASSESSING THE CAUSAL RELATIONSHIP BETWEEN SEPSIS AND AUTOIMMUNE: A MENDELIAN RANDOMIZATION STUDY. (2024/04/01) ♡
- Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis. (2024/04/01) ♡
- Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. (2024/03/29) ♡
- Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights. (2024/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study. (2024/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry. (2024/03/01) ♡
- Liver microvascular flow evaluation by texture analysis and quantitative contrast-enhanced ultrasound in pediatric chronic liver disease. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fungemia With Wickerhamomyces anomalus: A Case Report and Literature Review. (2024/02/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary Sclerosing Cholangitis: Epidemiology, Diagnosis, and Presentation. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic Tests in Primary Sclerosing Cholangitis: Serology, Elastography, Imaging, and Histology. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of Primary Sclerosing Cholangitis Including Transplantation. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence. (2024/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Autoimmune Hepatitis Including Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver Transplantation for Hilar Cholangiocarcinoma. (2024/02/01) ♡
- A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. (2024/02/01) ♡
- A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis. (2024/02/01) ♡
- Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. (2024/01/25) ♡
- Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. (2024/01/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Low Gamma-Glutamyl Transferase Cholestasis in a Patient With X-Linked Myotubular Myopathy and Crohn's Disease. (2024/01/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Rare benign obstructive disease of the biliary tract-a rare case of eosinophilic cholangitis. (2024/01/17) ♡
- Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study. (2024/01/17) ♡
- Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study. (2024/01/15) ♡
- Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models. (2024/01/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. (2024/01/10) ♡
- CLDN1 Arg81His founder variant causes ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis (ILVASC) syndrome in Moroccan Jews. (2024/01/01) ♡
- Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two? (2024/01/01) ♡
- Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: A single centre prospective study. (2024/01/01) ♡
- Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. CsHscB Derived from a Liver Fluke Clonorchis sinensis Ameliorates Cholestatic Hepatic Fibrosis in a Mouse Model of Sclerosing Cholangitis. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Well-differentiated neuroendocrine tumor of the ileal pouch in a patient with ulcerative colitis and primary sclerosing cholangitis: report of a case and review of the literature. (2024/01/01) ♡
- Impact of liver transplantation on intestinal and systemic inflammation markers in patients with colitis ulcerosa concomitant with primary sclerosing cholangitis. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease (2024-12-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. MRI Based Biomarkers in Pediatric Autoimmune Liver Disease (2024-12-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Endoscopy and Primary Sclerosing Cholangitis (2024-11-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography (2024-11-01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.